A number of studies have demonstrated that metabolic dysregulation, such as obesity, leads to the activation of the NLRP3 inflammasome in various cells, including PBMCs and endothelial cells. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.